Guangzhou Hanfang Offers SmallBatch Purchases for Injectable Soybean Oil

Customizable, Globally Compliant Injectable Excipient Meets Diverse Client Needs

【Guangzhou, China】– 2026 – Guangzhou Hanfang Pharmaceutical Company Limited, a leading provider of high-end pharmaceutical lipid excipients and traditional Chinese medicine modernization solutions, today announces that its injectable soybean oil product now supports small-batch purchase options for global pharmaceutical and specialty food clients. This initiative addresses the core pain point of unstable domestic supply for injectable-grade excipients, while offering flexible procurement terms to accommodate small-scale R&D projects, pilot productions, and customized manufacturing requirements. The injectable soybean oil, serving as an energy supplement and pharmaceutical excipient, is fully compliant with international standards and available for immediate global orders.

Core Product Advantages & Global Compliance

1. Small-Batch Purchase Flexibility: The injectable soybean oil supports small-batch orders to meet the varied production scales of pharmaceutical enterprises, research institutions, and specialty food manufacturers, enabling clients to test formulations or run limited productions without committing to large volumes.
2. Stable Domestic Supply: As a reliable domestic alternative to imported injectable-grade excipients, it reduces clients’ reliance on overseas sources and ensures consistent supply for critical manufacturing processes.
3. Global Regulatory Compliance: The product meets strict international standards, including EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI certifications, allowing access to over 20 countries and regions worldwide.

Procurement & Customization Services

The injectable soybean oil is now available for global orders via the official website (http://byshanhanfang.com/) and authorized distributors. In addition to standard small-batch options, Guangzhou Hanfang offers customized processing services to meet specific client requirements, including tailored formulations and packaging solutions.

Executive Quote

"The launch of small-batch purchase options for our injectable soybean oil underscores our commitment to addressing diverse client needs across the pharmaceutical and specialty food sectors," said Xu Wendong, General Manager and Deputy Director of the National Engineering Research Center at Guangzhou Hanfang Pharmaceutical Company Limited. "By combining stable domestic supply with flexible procurement terms, we aim to support global clients in accelerating their R&D and production processes, while contributing to the self-reliance of the domestic pharmaceutical industry."

Industry Context & Strategic Alignment

The global pharmaceutical excipient market is seeing increasing demand for flexible supply solutions, particularly for small-scale and customized production projects. Guangzhou Hanfang’s initiative aligns with this trend, leveraging its national-level R&D platforms and manufacturing capabilities to provide reliable, compliant products that meet both domestic and international client needs.

Future Plans

Looking ahead, Guangzhou Hanfang Pharmaceutical Company Limited will continue to expand its small-batch purchase services to more of its high-end pharmaceutical excipient products, including injectable egg yolk lecithin and medium-chain triglycerides. The company also plans to enhance its global distribution network to provide faster delivery and localized support for clients in key markets.

About Guangzhou Hanfang Pharmaceutical Company Limited

Founded in 1998, Guangzhou Hanfang Pharmaceutical Company Limited is a core modern pharmaceutical enterprise under the Guangyao Group, specializing in high-end pharmaceutical lipid excipients, specialty anti-tumor APIs, and Ganoderma health products. It is a national-level specialized and sophisticated "Little Giant" enterprise, housing the only national engineering research center for traditional Chinese medicine engineering technology in China. With products sold to over 20 countries and regions, the company’s mission is to achieve technological self-reliance, solve industry "bottleneck" problems, and safeguard the safety of the pharmaceutical industry chain. More information is available at http://byshanhanfang.com/.